Journal of drug targeting · 2002 · 12 citations · 23 references
PharmacyBiotechnologyMolecular BiologyDrug DeliveryGene DeliveryMolecular BiotechnologyBlood-brain Barrier DeliveryGene Delivery SystemsGene Delivery VectorsIn Vivo Gene DeliveryLipid-based Gene CarriersPlasmid Dna DeliveryGene Delivery Across The Blood-brain BarrierLipid-based Brain Delivery SystemsLipid-based VectorsLiposome Delivery SystemsLiposomesVirally Derived Delivery VectorsWestern Blot Analysis
Bioactive proteins or peptides cannot be effectively delivered into brain capillary endothelial cells (BCECs) or brain parenchyma. In this study, we selectively transferred Escherichia coli beta-galactosidase gene (beta-gal) as a model gene into BCECs by using the hemagglutination virus of Japan (HVJ)-liposomes. HVJ-liposomes encapsulating a beta-gal plasmid were used to transfect MBEC4 cells in vitro, and were administrated via the internal carotid artery to rat in vivo. Success of the procedure was confirmed by the detection of 116 kDa beta-gal protein in transfected MBEC4 cells and in brain capillaries isolated from transfected rats, by Western blot analysis and histological staining. The enzymatic activities of beta-galactosidase were 5- to 10-fold and 20-fold higher than when beta-gal-containing liposomes without fusogenic activity (uncoated liposomes) or plasmid alone were employed in vitro and in vivo, respectively. Thus, HVJ-liposomes were demonstrated to be a useful vector to transfer a foreign gene into the brain capillary endothelium in vivo via the transluminal route.
23
Deniz Kirik, Carl Rosenblad, Anders Björklund et al. · Journal of Neuroscience · 2000 · 432 citations · Full text
Functional involvement of P-glycoprotein in blood-brain barrier.
T Tatsuta, Mikihiko Naito, Tomoko Oh‐hara et al. · Journal of Biological Chemistry · 1992 · 353 citations · Full text
Medicine, Cell Biology, Pharmacology +17